Harvard Endowment Leader Stephen Blyth on Medical Leave

Stephen Blyth on temporary leave of absence 

Stephen Blyth
Photograph by Stephanie Mitchell/Harvard Public Affairs and Communications

The University announced this morning that Stephen Blyth, president and chief executive officer of Harvard Management Company—which invests the endowment assets—is taking a temporary medical leave of absence, effective immediately. Blyth assumed his current responsibilities just 17 months ago, effective January 1, 2015, and was engaged in a thorough review and redirection of the management company and its investment processes, as described here, after a period of disappointing investment returns. Apart from the obvious personal concerns for Blyth’s health, his absence comes at a challenging time for the organization. The University statement follows; given the personal nature of the announcement, no further details are being released at this time.

Harvard Management Company, Inc. (HMC) today announced that Stephen Blyth, HMC’s President and Chief Executive Officer, will take a temporary medical leave of absence. The temporary leave takes effect today, Monday, May 23.

HMC’s Board of Directors have appointed Robert Ettl, HMC’s Chief Operating Officer, as interim CEO until Mr. Blyth’s return. Mr. Ettl joined HMC in 2008.

In the interim period, Rene Canezin, Head of Fixed Income, Credit, and Commodities, and Rich Hall, Head of Private Equity, will serve as co-chairs of HMC's Investment Committee.

“We have a highly-experienced executive team at HMC and, together with Bob, they will provide strong leadership in Stephen's absence,” said Paul J. Finnegan, Chair of HMC’s Board of Directors. “We look forward to Stephen's return to the company, and wish him well as he returns to full health."

 

 

You might also like

Sustainability on the Menu

Harvard’s sustainable meals program aims to support local farms, protect oceans, and limit waste.

What of the Humble Pencil?

Review: At the Harvard Art Museums’ new exhibit, drawing takes center stage

Harvard Research Funding Will Resume, Government Signals

Notices of grant reinstatements follow a court ruling, but the Trump administration could still appeal. 

Most popular

Two Years of Doxxing at Harvard

What happens when students are publicly named and shamed for their views?

A New Narrative of Civil Rights

Political philosopher Brandon Terry’s vision of racial progress

How MAGA Went Mainstream at Harvard

Trump, TikTok, and the pandemic are reshaping Gen Z politics.

Explore More From Current Issue

Illustration of scientists injecting large syringe with mitochondria into human heart.

Do Mitochondria Hold the Power to Heal?

From Alzheimer’s to cancer, this tiny organelle might expand treatment options. 

Whimsical illustration of students rushing through ornate campus gate from bus marked “Welcome New Students.”

Highlights From Harvard’S Past

The Medical School goes coed, University poet wins Nobel Prize. 

James Muller in white lab coat leaning on railing in hospital hallway.

Free Speech, the Bomb—And Donald Trump

A Harvard cardiologist on the unlikely alliances that shaped a global movement to prevent nuclear war